Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 370

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Urinary Biomarkers in the Clinical Prognosis and Early Detection of Acute Kidney Injury

Open access
Koyner, Jay L., Vaidya, Vishal S., Bennett, Michael R., Ma, Qing, Worcester, Elaine, Akhter, Shahab A., Raman, Jai, Jeevanandam, Valluvan, O'Connor, Micheal F., Devarajan, Prasad, Bonventre, Joseph V., Murray, Patrick T.·2010·Clinical Journal of the American Society of Nephrology

Abstract

BACKGROUND AND OBJECTIVES: Several novel urinary biomarkers have shown promise in the early detection and diagnostic evaluation of acute kidney injury (AKI). Clinicians have limited tools to determine which patients will progress to more severe forms of AKI at the time of serum creatinine increase. The diagnostic and prognostic utility of novel and traditional AKI biomarkers was evaluated during a prospective study of 123 adults undergoing cardiac surgery. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Urinary neutrophil gelatinase-associated lipocalin (NGAL), cystatin C (CyC), kidney injury molecule-1 (KIM-1), hepatocyte growth factor (HGF), π-glutathione-S-transferase (π-GST), α-GST, and fractional excretions of sodium and urea were all measured at preoperative baseline, postoperatively, and at the time of the initial clinical diagnosis of AKI. Receiver operator characteristic curves were generated and the areas under the curve (AUCs) were compared. RESULTS: Forty-six (37.4%) subjects developed AKI Network stage 1 AKI; 9 (7.3%) of whom progressed to stage 3. Preoperative KIM-1 and α-GST were able to predict the future development of stage 1 and stage 3 AKI. Urine CyC at intensive care unit (ICU) arrival best detected early stage 1 AKI (AUC = 0.70, P < 0.001); the 6-hour ICU NGAL (AUC = 0.88; P < 0.001) best detected early stage 3 AKI. π-GST best predicted the progression to stage 3 AKI at the time of creatinine increase (AUC = 0.86; P = 0.002). CONCLUSION: Urinary biomarkers may improve the ability to detect early AKI and determine the clinical prognosis of AKI at the time of diagnosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2215/cjn.00740110

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 370

Metadata

Authors
Koyner, J. L., Vaidya, V. S., Bennett, M. R., Ma, Q., Worcester, E., Akhter, S. A., Raman, J., Jeevanandam, V., O'Connor, M. F., Devarajan, P., Bonventre, J. V., & Murray, P. T.
Venue
Clinical Journal of the American Society of Nephrology
Published
2010-12
Volume
5
Issue
12
Pages
2154-2165
ISSN
1555-9041 (ISSN-L)
OpenAlex
W2104305817
Cited by
370
References
36
FWCI
24.28
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urinary Biomarkers in the Clinical Prognosis and Early Detection of Acute Kidney Injury. https://app.cochat.ai/papers/10.2215/cjn.00740110
The paper
Koyner, J. L., Vaidya, V. S., Bennett, M. R., Ma, Q., Worcester, E., Akhter, S. A., Raman, J., Jeevanandam, V., O'Connor, M. F., Devarajan, P., Bonventre, J. V., & Murray, P. T. (2010). Urinary Biomarkers in the Clinical Prognosis and Early Detection of Acute Kidney Injury. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.00740110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.